LEVELS OF PROINFLAMMATORY CYTOKINES IL-17 AND IL-23 IN PATIENTS WITH ALZHEIMER'S DISEASE, MILD COGNITIVE IMPAIRMENT AND VASCULAR DEMENTIA.

Objective: The aim: To research differences of interleukin (IL)-17 and IL-23 serum levels in patients with Alzheimer's disease, vascular dementia and mild cognitive impairment.

Patients And Methods: Material and methods: Serum levels of IL-17 and IL-23 were measure by ELISA for 15 patients with Alzheimer's disease, 14 with vascular dementia, 30 with mild cognitive impairment and 30 control individuals without cognitive impairment.

Results: Results: Serum concentrations of IL-17 were significantly higher in Alzheimer's disease patients (P=0.